investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
Edward L Schwartz
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Edward L Schwartz
Albert Einstein College of Medicine
Bronx, United States
Related projects
Gwen Lomberk
Novel Experimental Therapeutics for Pancreatic Cancer
Pancreas
Pathology
Alec Kimmelman
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
Pancreas
Radiation Oncology
Keping Xie
Molecular Mediators of Pancreatic Cancer Invasion and Progression
Pancreas
Pathology
Vladimir Bogdanov
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
Pancreas
Pathology
Jonathan R Pollack
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer
Pancreas
Pathology
Gary Rosenberg
AP 1. Biodiversity
Pancreas
Marilyn D Resh
Hedgehog Acyltransferase as a target in cancer
Pancreas
Udo Rudloff
Preclinical Drug Development in Pancreatic Cancer
Pancreas
Pathology
Robert M Straubinger
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
Pancreas
Pathology